Legend Biotech Corporation Reports Q2 and H1 2023 Financials with Increased Revenues and R&D Spending
Legend Biotech Corporation (NASDAQ: LEGN) has released its financial results for the second quarter and...
Sanofi Misses Out on Acquiring Reata Pharmaceuticals to Biogen in USD 7.3 Billion Deal
Media outlet Bloomberg reported today that France-based Sanofi (NASDAQ: SNY) lost a bidding war to...
Sandoz Achieves Primary Endpoint in Phase III Trial for Biosimilar Aflibercept
Switzerland-based Novartis (NYSE: NVS) subsidiary Sandoz (SWX: SDZ) has announced that a Phase III confirmatory...
Gilead Sciences Enters Collaboration with Tentarix Biotherapeutics for Polyspecific Antibodies
Gilead Sciences (NASDAQ: GILD) has announced the initiation of three collaboration programs with US-based Tentarix...
Amoy Diagnostics and AstraZeneca Expand Collaboration on Companion Diagnostic Development
China-based Amoy Diagnostics Co., Ltd (AmoyDx, SHE: 300685) has announced a new cooperation agreement with...
YiChang HEC ChangJiang Pharmaceutical’s Yiqibuvir Receives NMPA Review for Hepatitis C Treatment
China-based YiChang HEC ChangJiang Pharmaceutical Co., Ltd (HKG: 1558) has announced that the National Medical...
Everest Medicines’ Partner Venatorx Pharmaceuticals Receives FDA Priority Review for Cefepime-Taniborbactam
China-based Everest Medicines (HKG: 1952) announced that its partner, Venatorx Pharmaceuticals, has received acceptance from...
CStone Pharmaceuticals Reports 2023 Interim Financials and Business Milestones
China-based CStone Pharmaceuticals (HKG: 2616) has announced its 2023 interim financial results alongside key business...
HitGen Inc. Partners with Nested Therapeutics for Precision Medicine Research
China-based HitGen Inc. (SHA: 688222) has announced a research service agreement with Cambridge, Massachusetts-based precision...
Simcere Pharmaceutical’s Cosela Receives NMPA Review for ES-SCLC Indication
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced that the National Medical Products Administration (NMPA)...
Suzhou Leadsynbio Secures Series D Funding to Boost R&D and Market Presence
Suzhou Leadsynbio Technology Co., Ltd, a specialist in synthetic biology, has reported raised hundreds of...
SinoMab BioScience Receives NMPA Approval for Phase I Clinical Study of SM17 Asthma Therapy
Hong Kong-based biotech company SinoMab BioScience Ltd (HKG: 3681) has announced that it has received...
Jiangsu Hengrui Pharmaceuticals Strikes Licensing Deal with One Bio Inc. for TSLP-Targeted mAb SHR1905
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced a significant licensing agreement with...
J&J Subsidiary Janssen Wins FDA Approval for Akeega in BRCA-Positive mCRPC Treatment
The US Food & Drug Administration (FDA) has granted marketing approval to Johnson & Johnson...
Medivir’s Fostrox in Combination with Lenvima Shows Promise in Phase IIa HCC Trial
Sweden-based Medivir (STO: MVIR) has released interim data from a Phase IIa trial evaluating the...
AstraZeneca to Invest Additional USD 250 Million in Qingdao for Aerosol Production Plant
UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) is set to invest an additional USD 250...
Eli Lilly Expands Portfolio with Acquisitions of Sigilon Therapeutics and Versanis Bio
Eli Lilly (NYSE: LLY) has completed the separate purchases of US compatriots Sigilon Therapeutics (NASDAQ:...
NHC Addresses Anti-Corruption Efforts in Pharmaceutical Industry Nationwide
The National Health Commission (NHC) convened a conference to address questions on the ongoing anti-corruption...
Pfizer’s Elrexfio Earns Accelerated FDA Approval for Relapsed/Refractory Multiple Myeloma
This week, Pfizer (NYSE: PFE) received an accelerated approval from the US Food and Drug...
Novartis Acquires Chinook Therapeutics for $3.2 Billion, Eyes Kidney Disease Market
Switzerland-based pharmaceutical major Novartis (NYSE: NVS) has successfully completed the scheduled purchase of US-based kidney...